Home News International

International

Glenmark Pharma opens new facility in Switzerland

New Delhi, June 10, 2014 - Glenmark Pharmaceuticals, on Wednesday, said its wholly-owned subsidiary, Glenmark Pharmaceuticals S.A., opened its new cGMP (current good manufacturing practice)-compliant monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland. An antibody or immunoglobulin is a...

WACKER Opens Logistics Center at Amtala Production Site

Amtala, July 9, 2014 – The Munich-based chemical group WACKER announced the opening of a new logistics facility at its production site in Amtala near Kolkata today. The high-bay warehouse has a capacity of 5000 pallet spaces and will...

Dr Reddy’s launches anti-depressant generic in US

HYDERABAD, July 05, 2014 : Pharma major Dr Reddy's Laboratories has launched Duloxetine delayed release capsules in the US market. The anti-depressant drug is the generic equivalent of Cymbalta. The brand and generic had a sales of $5 billion...

Lupin launches generic Niaspan tablets in US market

New Delhi, March 22,2014 - Mumbai-based pharma major Lupin Ltd today launched its generic version of Niaspan extended release tablets, used in reducing cholesterol in the US market. The company’s US subsidiary, Lupin Pharmaceuticals Inc has launched the...

Health tops new Nestle MD’s agenda

Mumbai, April 02,2014 - The attention in the new financial year will not only be on Saugata Gupta and Varun Berry , newly appointed managing directors (MDs) of Marico and Britannia, respectively. Another recently appointed MD is vying for attention — Etienne Benet of Nestle. Benet, who took over...

GE Healthcare, CTSI team up to launch 25 cancer treatment centres

To invest Rs.720 cr during the next five years to roll out units Bangalore, March 29, 2014 - GE Healthcare and Cancer Treatment Services International have announced plans to launch 25 cancer detection and treatment centres all over India...

India Signs Loan Agreements with World bank for IDA Assistance of US $ 100...

New Delhi, May 31, 2014 - Credit Agreement for World Bank (IDA) assistance of US$ 100 million for Accelerating Universal Access to Early and Effective Tuberculosis Care has been signed between the Government of India and the World Bank here...

Watson Completes Actavis Acquisition

Creates 3rd largest global generics company with presence in 60+ markets$8.0+ billion anticipated pro forma combined 2012 revenueCombined management structured to immediately maximize combination value

PARSIPPANY, N.J. – October 31, 2012 – Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it has completed the acquisition of the Actavis Group for EUR4.25 billion. The combination creates the world’s third largest generic pharmaceutical company, with anticipated pro forma combined 2012 revenues in excess of $8 billion.

Medical Material Database Company Launches in India; Carna Medical Database to Establish a Medical...

New Delhi, Wednesday, December 18, 2013: Konoike Transport and Medius Holdings with their head offices in Tokyo have come together in a 70-30 joint venture to launch their Indian arm Carna Medical Database Pvt. Ltd. The Indian company has...

Bayer HealthCare completes acquisition of Teva’s U.S. animal health business

New product lines strengthen Bayer’s animal health business in the U.S.

Leverkusen, January 4, 2013 – Bayer HealthCare announced today that it has received the necessary regulatory approval from the Federal Trade Commission to complete the acquisition of the U.S.-based animal health business of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA). As announced in September 2012, Bayer will pay up to 145 million USD which includes an upfront payment of 60 million USD plus a total of 85 million USD in milestone payments, which are linked to the successful and timely achievement of manufacturing and sales targets. The transaction includes a manufacturing site in St. Joseph, Missouri and around 300 employees.